ACE Report Cover
BioCleanse for BTB allografts in ACL rupture performs comparably to the aseptic technique
Language
Download
Cite
+ Favorites
Language
Download
Cite
+ Favorites
AceReport Image
SPORTS MEDICINE
BioCleanse for BTB allografts in ACL rupture performs comparably to the aseptic technique .
Verified
This report has been verified by one or more authors of the original publication.

Aseptically processed and chemically sterilized BTB allografts for anterior cruciate ligament reconstruction: a prospective randomized study

Knee Surg Sports Traumatol Arthrosc. 2013 Sep;21(9):2107-12
Exclusive Author Interview

Dr. Peter Indelicato discusses the effects of irradiation on allografts tissue for ACL reconstruction and develops the rationale for the BioCleanse study presented in this ACE Report.

67 patients with an acute (<4 months), isolated, unilateral ACL rupture were randomized to evaluate the efficacy of the BioCleanse sterilization technique against traditional aseptic processing for bone-patellar tendon-bone (BTB) allografts. Patients were assessed over 24 months using the International Knee Documentation Committee (IKDC) form outcome, range of motion (ROM) effusion and a KT-1000 knee arthrometer test. This study demonstrates that the use of the BioCleanse technique exhibits similar clinical outcomes to aseptic processing for BTB allografts and that no complications were associated with BioCleanse use.

Unlock the Full ACE Report

You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now

Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics

Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics

Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions

Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics

Or upgrade today and gain access to all OrthoEvidence
content for as little as $1.99 per week.
0 of 4 monthly FREE articles unlocked
You've reached your limit of 4 free articles views this month

Access to OrthoEvidence for as little as $1.99 per week.

Stay connected with latest evidence. Cancel at any time.
  • Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
  • Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
  • Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Upgrade
Welcome Back!
Forgot Password?
Start your FREE trial today!

Account will be affiliated with


OR
Forgot Password?

OR
Please check your email

If an account exists with the provided email address, a password reset email will be sent to you. If you don't see an email, please check your spam or junk folder.

For further assistance, contact our support team.

Translate ACE Report

OrthoEvidence utilizes a third-party translation service to make content accessible in multiple languages. Please note that while every effort is made to ensure accuracy, translations may not always be perfect.

Cite this ACE Report

OrthoEvidence. BioCleanse for BTB allografts in ACL rupture performs comparably to the aseptic technique. ACE Report. 2014;3(1):13. Available from: https://myorthoevidence.com/AceReport/Show/biocleanse-for-btb-allografts-in-acl-rupture-performs-comparably-to-the-aseptic-technique

Copy Citation
Please login to enable this feature

To access this feature, you must be logged into an active OrthoEvidence account. Please log in or create a FREE trial account.

Premium Member Feature

To access this feature, you must be logged into a premium OrthoEvidence account.

Share this ACE Report